Baillie Gifford & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02B | Sell |
19,985,876
-594,638
| -3% | -$27.7M | 1.04% | 22 |
|
|
2025
Q4 | $607M | Sell |
20,580,514
-1,266,152
| -6% | -$34.4M | 0.5% | 41 |
|
|
2025
Q3 | $564M | Sell |
21,846,666
-247,458
| -1% | -$6.9M | 0.42% | 47 |
|
|
2025
Q2 | $610M | Sell |
22,094,124
-2,854,434
| -11% | -$75.2M | 0.46% | 41 |
|
|
2025
Q1 | $707M | Sell |
24,948,558
-13,941,013
| -36% | -$495M | 0.62% | 34 |
|
|
2024
Q4 | $1.62B | Sell |
38,889,571
-3,568,512
| -8% | -$171M | 1.24% | 22 |
|
|
2024
Q3 | $2.84B | Sell |
42,458,083
-990,958
| -2% | -$91M | 2.12% | 15 |
|
|
2024
Q2 | $5.16B | Sell |
43,449,041
-1,206,776
| -3% | -$153M | 4.02% | 4 |
|
|
2024
Q1 | $4.76B | Sell |
44,655,817
-998,710
| -2% | -$101M | 3.7% | 5 |
|
|
2023
Q4 | $4.54B | Buy |
45,654,527
+5,344
| +0% | +$449K | 3.6% | 7 |
|
|
2023
Q3 | $4.72B | Sell |
45,649,183
-61,912
| -0.1% | -$6.91M | 4.3% | 5 |
|
|
2023
Q2 | $5.55B | Sell |
45,711,095
-755,076
| -2% | -$101M | 4.72% | 4 |
|
|
2023
Q1 | $7.14B | Buy |
46,466,171
+1,679,425
| +4% | +$277M | 6.44% | 2 |
|
|
2022
Q4 | $8.04B | Sell |
44,786,746
-493,277
| -1% | -$80.7M | 8.38% | 1 |
|
|
2022
Q3 | $5.35B | Sell |
45,280,023
-279,768
| -0.6% | -$42.5M | 5.52% | 2 |
|
|
2022
Q2 | $6.51B | Sell |
45,559,791
-69,435
| -0.2% | -$9.92M | 6.67% | 1 |
|
|
2022
Q1 | $7.86B | Sell |
45,629,226
-142,853
| -0.3% | -$24.1M | 5.51% | 2 |
|
|
2021
Q4 | $11.6B | Buy |
45,772,079
+3,554,725
| +8% | +$1.04B | 6.38% | 1 |
|
|
2021
Q3 | $16.2B | Sell |
42,217,354
-3,665,859
| -8% | -$1.35B | 8.5% | 1 |
|
|
2021
Q2 | $10.8B | Buy |
45,883,213
+545,449
| +1% | +$97.5M | 5.25% | 1 |
|
|
2021
Q1 | $5.94B | Buy |
45,337,764
+21,025,493
| +86% | +$3.05B | 3.32% | 7 |
|
|
2020
Q4 | $2.54B | Buy |
24,312,271
+17,086,635
| +236% | +$1.73B | 1.41% | 15 |
|
|
2020
Q3 | $511M | Buy |
7,225,636
+3,166,153
| +78% | +$221M | 0.35% | 57 |
|
|
2020
Q2 | $261M | Buy |
4,059,483
+499,599
| +14% | +$27.4M | 0.2% | 83 |
|
|
2020
Q1 | $107M | Buy |
3,559,884
+143,771
| +4% | +$3.31M | 0.12% | 99 |
|
|
2019
Q4 | $66.8M | Buy |
3,416,113
+201,316
| +6% | +$3.57M | 0.06% | 113 |
|
|
2019
Q3 | $51.2M | Buy |
3,214,797
+7,202
| +0.2% | +$106K | 0.06% | 120 |
|
|
2019
Q2 | $47M | Buy |
3,207,595
+632,394
| +25% | +$13.6M | 0.05% | 126 |
|
|
2019
Q1 | $52.4M | Buy |
2,575,201
+849,357
| +49% | +$15.8M | 0.06% | 120 |
|
|
2018
Q4 | $26.4M | Buy |
+1,725,844
| New | +$28.4M | 0.03% | 139 |
|
Other funds holding MRNA
VCM
VPM
TP